Login
Register
Help
Keep me logged in
Sign in
Forgot Password?
Lippincott CME
Connection
Main Menu
Home
Browse
My Planner
My Transcripts
Register
Help
Search Keywords
Toggle Dropdown
Advanced Search »
Lenvatinib vs. Sorafenib as First-Line Treatment for Unresectable HCC
Topic
Lenvatinib vs. Sorafenib as First-Line Treatment for Unresectable HCC
Viewing 1–0 of 0
«
of 0
»
Show
5 per page
10 per page
20 per page
50 per page
Sort
Title
Title
Date Published
Date Published
Date Expires
Date Expires
Credit
Credit
Viewing 1–0 of 0
«
of 0
»
